The Catalan economy contracted by 0.3% between July and September, although its results improved slightly compared to the previous quarter, when it shrunk by 0.5%. The tourism sector continues to grow and internal consumption continues to drop. Compared to a year ago, by the end of September, Catalan GDP has fallen by 1.4%.
The production of the new Seat León, the brand’s flagship model, guarantees 1,600 direct jobs and 6,000 indirect ones in the supply industries. The car manufacturing company, owned by Volkswagen, has its only plant in Martorell, Greater Barcelona. The company has great expectations of the new Seat León, which will be distributed worldwide from Catalonia. The new car model is the milestone of Seat’s commercial and strategic plan for this year, with the objective of becoming profitable again. It will be sold in three different versions: a five-door and a three-door model, and a station wagon car.
Catalonia hosts one of the world’s five active potash mines. The company Iberpotash has started to implement its Phoenix Plan, which foresees investing €600 million until 2020. The first phase of the project is the construction of a 4.7 kilometre tunnel to transport the potash mineral extracted from the mine to the treatment plant. The tunnel represents an important environmental improvement, as lorries carrying potash will no longer pass through the town of Súria. They will pass through the tunnel 900 metres under the ground. This first phase will enable the improvement of the mine’s productivity to between 30 and 40%.
The chemical industries based in Tarragona, such as BASF, Dow Chemical and Repsol, expect their turnover to increase by 4% in 2012 compared to a year ago. In 2011, they exported 60% of their production, while in 2000 they were only exporting 30% of it. Furthermore, they have requested transport infrastructures to be improved and criticised the increase in energy taxes. About Catalonia’s hypothetical independence, they stated they “will respect what will be decided and will adapt to it”. These companies represent around 7% of Catalonia’s GDP.
The expansion to Brazil is part of the company’s international development plan, which aims to start operations in Latin America, the Middle East and Asia. The company hopes to replicate its successful European business model overseas and has started with the opening of new offices in São Paulo. Galenicum, a developer of generic medicines, is based in Barcelona and produced a turnover of €77 million in 2011, a 542% increase in just two years.
The economic crisis hits Catalan industrial areas. In Catalonia there is a total of 35,000 hectares of industrial plots of land. Up to 40% of this surface has no use after four consecutive years of losing activity, and during this time there have been more industrial buildings closing than opening.
Sales of industrial goods to non-EU markets increased by 28% between January and March. Catalan industry reached a record in 2011 by exporting €55.19 billion in goods. However, the sector continues to lose jobs, which makes it more competitive in return. Also, industrial investment increased by 2.4% in 2011.
Compared to the rest of industrialised countries, Catalonia’s industrial sector improved its competitiveness index by 0.7% between October and December 2011, compared to the same period a year earlier. Catalan industrial prices have been improving their competitiveness since 2009.
The multinational chemical company explains that they would invest more money if the Mediterranean Railway Corridor were already a reality. This infrastructure is being delayed by the Spanish Government and it would enable the transportation of freight on international standard width railway from Catalan ports to Central Europe, and vice versa.
The Catalan pharmaceutical company Grífols, third worldwide company in plasma derivatives, has signed a cooperation agreement with the Shanghai Blood Bank. The agreement, which strengthens the presence of the Catalan company in China, promotes blood genotyping research. The Chinese institution will use the Grifols’ genetic test BLOODchip in transfusion compatibility studies. Shanghai Blood Bank serves over 20 million people and receives more than 300.000 donations per year. In 2011, Grifols sales in China grew by 30%.
Four days on the Gaudí catwalk and over 230 national and international exhibitors in the Gran Via fairground reaffirmed the convention as the quintessential meeting of the bridal industry worldwide. The Catalan designer Rosa Clarà was chosen another year to open the four days of catwalks at the ‘Pasarela Gaudí Novias’. Exports from Catalan wedding products made the industry generate a turnover of 10% more than in 2010. Currently, the industry is opening to Mexico and China.
This year's edition Mobile World Congress will be the first after Barcelona was officially declared the Mobile World Capital, and the organising city of this annual event until at least 2018. The MWC will start on February 27th with the motto “Redefining mobile”. More than 1,400 companies will be present and organisers expect to break last year’s records. There will also be three times more Catalan companies.
The Franco-Japanese company has chosen the Catalan car component manufacturer Ficosa as their only automatic gearbox supplier for all the new cars targeting a middle-class market segment. The agreement is for the European, North-American, South-American and Asian markets. It will represent a sales volume of 45 million euros for Ficosa. The news reinforces Greater Barcelona as a base for the automotive industry.
The world’s leader chemical company is planning to invest 12 million euros in its Tarragona plant, the largest one in southern Europe. BASF Spain has its headquarters in Tarragona, and concentrates most of its plants and offices in Catalonia.
The factory will increase its output of biological and pharmaceutical products by 40% over 3 years, taking work from closing factories in Europe and the United States. The Catalan plant is specialised in animal health and vaccines for livestock. It was bought in 2009 by the North American pharmaceutical giant, in a small town near Girona.